Wheal and flare responses to opioids in humans

J. H. Levy, N. W. Brister, A. Shearin, J. Ziegler, C. C. Hug, David Adelson, B. F. Walker

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Certain opioids release histamine from cutaneous mast cells to produce local wheal and flare responses and adverse hemodynamic effects. In vivo responses to opioids suggest that cutaneous responses result from the interaction of opioids with opioid receptors on human mast cells. There are no data evaluating or comparing the opioids currently used in anesthesia. Volunteers were injected intradermally with different opioids as well as with naloxone and antihistamines to evaluate their effects on cutaneous mast cell reactivity and cutaneous vascular responses. Fentanyl and morphine produced concentration-dependent wheal and flare responses in the range of 5 x 10-6 M to 1.5 x 10-3 M. Volunteers were then tested intradermally with different opioids and histamine at a 5 x 10-4 M concentration to determine their relative cutaneous effects. Morphine, meperidine, fentanyl, and sufentanil produced both wheal and flare responses that were significantly greater than those due to saline (P <0.05). Naloxone, alfentanil, and nalbuphine did not produce significant wheal or flare responses. Butorphenol was followed by a significant wheal but no flare. Naloxone attenuated cutaneous wheal and flare responses to fentanyl and the flare response to morphine. Intradermal antihistamines (diphenhydramine and cimetidine) produced significant wheal and flare responses. Electron micrographs of biopsies from fentanyl-induced wheals demonstrated normal mast cell architecture with no evidence of mast cell degranulation. Opioid effects on wheal and flare responses and mast cell degranulation appear independent of opioid analgesic potency. Opioids produce cutaneous vascular responses dependent on both histamine release from mast cells and direct effects on the vasculature. Wheal and flare responses of opioids appear to represent an indicator of systemic histamine release only if they are of the same magnitude as that produced by an equimolar intradermal histamine injection.

Original languageEnglish (US)
Pages (from-to)756-760
Number of pages5
JournalAnesthesiology
Volume70
Issue number5
StatePublished - 1989
Externally publishedYes

Fingerprint

Opioid Analgesics
Mast Cells
Skin
Fentanyl
Histamine Release
Naloxone
Morphine
Cell Degranulation
Histamine Antagonists
Histamine
Blood Vessels
Volunteers
Nalbuphine
Sufentanil
Alfentanil
Diphenhydramine
Intradermal Injections
Meperidine
Cimetidine
Opioid Receptors

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Levy, J. H., Brister, N. W., Shearin, A., Ziegler, J., Hug, C. C., Adelson, D., & Walker, B. F. (1989). Wheal and flare responses to opioids in humans. Anesthesiology, 70(5), 756-760.

Wheal and flare responses to opioids in humans. / Levy, J. H.; Brister, N. W.; Shearin, A.; Ziegler, J.; Hug, C. C.; Adelson, David; Walker, B. F.

In: Anesthesiology, Vol. 70, No. 5, 1989, p. 756-760.

Research output: Contribution to journalArticle

Levy, JH, Brister, NW, Shearin, A, Ziegler, J, Hug, CC, Adelson, D & Walker, BF 1989, 'Wheal and flare responses to opioids in humans', Anesthesiology, vol. 70, no. 5, pp. 756-760.
Levy JH, Brister NW, Shearin A, Ziegler J, Hug CC, Adelson D et al. Wheal and flare responses to opioids in humans. Anesthesiology. 1989;70(5):756-760.
Levy, J. H. ; Brister, N. W. ; Shearin, A. ; Ziegler, J. ; Hug, C. C. ; Adelson, David ; Walker, B. F. / Wheal and flare responses to opioids in humans. In: Anesthesiology. 1989 ; Vol. 70, No. 5. pp. 756-760.
@article{92bf2741cae64195bf09ff4a14918743,
title = "Wheal and flare responses to opioids in humans",
abstract = "Certain opioids release histamine from cutaneous mast cells to produce local wheal and flare responses and adverse hemodynamic effects. In vivo responses to opioids suggest that cutaneous responses result from the interaction of opioids with opioid receptors on human mast cells. There are no data evaluating or comparing the opioids currently used in anesthesia. Volunteers were injected intradermally with different opioids as well as with naloxone and antihistamines to evaluate their effects on cutaneous mast cell reactivity and cutaneous vascular responses. Fentanyl and morphine produced concentration-dependent wheal and flare responses in the range of 5 x 10-6 M to 1.5 x 10-3 M. Volunteers were then tested intradermally with different opioids and histamine at a 5 x 10-4 M concentration to determine their relative cutaneous effects. Morphine, meperidine, fentanyl, and sufentanil produced both wheal and flare responses that were significantly greater than those due to saline (P <0.05). Naloxone, alfentanil, and nalbuphine did not produce significant wheal or flare responses. Butorphenol was followed by a significant wheal but no flare. Naloxone attenuated cutaneous wheal and flare responses to fentanyl and the flare response to morphine. Intradermal antihistamines (diphenhydramine and cimetidine) produced significant wheal and flare responses. Electron micrographs of biopsies from fentanyl-induced wheals demonstrated normal mast cell architecture with no evidence of mast cell degranulation. Opioid effects on wheal and flare responses and mast cell degranulation appear independent of opioid analgesic potency. Opioids produce cutaneous vascular responses dependent on both histamine release from mast cells and direct effects on the vasculature. Wheal and flare responses of opioids appear to represent an indicator of systemic histamine release only if they are of the same magnitude as that produced by an equimolar intradermal histamine injection.",
author = "Levy, {J. H.} and Brister, {N. W.} and A. Shearin and J. Ziegler and Hug, {C. C.} and David Adelson and Walker, {B. F.}",
year = "1989",
language = "English (US)",
volume = "70",
pages = "756--760",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Wheal and flare responses to opioids in humans

AU - Levy, J. H.

AU - Brister, N. W.

AU - Shearin, A.

AU - Ziegler, J.

AU - Hug, C. C.

AU - Adelson, David

AU - Walker, B. F.

PY - 1989

Y1 - 1989

N2 - Certain opioids release histamine from cutaneous mast cells to produce local wheal and flare responses and adverse hemodynamic effects. In vivo responses to opioids suggest that cutaneous responses result from the interaction of opioids with opioid receptors on human mast cells. There are no data evaluating or comparing the opioids currently used in anesthesia. Volunteers were injected intradermally with different opioids as well as with naloxone and antihistamines to evaluate their effects on cutaneous mast cell reactivity and cutaneous vascular responses. Fentanyl and morphine produced concentration-dependent wheal and flare responses in the range of 5 x 10-6 M to 1.5 x 10-3 M. Volunteers were then tested intradermally with different opioids and histamine at a 5 x 10-4 M concentration to determine their relative cutaneous effects. Morphine, meperidine, fentanyl, and sufentanil produced both wheal and flare responses that were significantly greater than those due to saline (P <0.05). Naloxone, alfentanil, and nalbuphine did not produce significant wheal or flare responses. Butorphenol was followed by a significant wheal but no flare. Naloxone attenuated cutaneous wheal and flare responses to fentanyl and the flare response to morphine. Intradermal antihistamines (diphenhydramine and cimetidine) produced significant wheal and flare responses. Electron micrographs of biopsies from fentanyl-induced wheals demonstrated normal mast cell architecture with no evidence of mast cell degranulation. Opioid effects on wheal and flare responses and mast cell degranulation appear independent of opioid analgesic potency. Opioids produce cutaneous vascular responses dependent on both histamine release from mast cells and direct effects on the vasculature. Wheal and flare responses of opioids appear to represent an indicator of systemic histamine release only if they are of the same magnitude as that produced by an equimolar intradermal histamine injection.

AB - Certain opioids release histamine from cutaneous mast cells to produce local wheal and flare responses and adverse hemodynamic effects. In vivo responses to opioids suggest that cutaneous responses result from the interaction of opioids with opioid receptors on human mast cells. There are no data evaluating or comparing the opioids currently used in anesthesia. Volunteers were injected intradermally with different opioids as well as with naloxone and antihistamines to evaluate their effects on cutaneous mast cell reactivity and cutaneous vascular responses. Fentanyl and morphine produced concentration-dependent wheal and flare responses in the range of 5 x 10-6 M to 1.5 x 10-3 M. Volunteers were then tested intradermally with different opioids and histamine at a 5 x 10-4 M concentration to determine their relative cutaneous effects. Morphine, meperidine, fentanyl, and sufentanil produced both wheal and flare responses that were significantly greater than those due to saline (P <0.05). Naloxone, alfentanil, and nalbuphine did not produce significant wheal or flare responses. Butorphenol was followed by a significant wheal but no flare. Naloxone attenuated cutaneous wheal and flare responses to fentanyl and the flare response to morphine. Intradermal antihistamines (diphenhydramine and cimetidine) produced significant wheal and flare responses. Electron micrographs of biopsies from fentanyl-induced wheals demonstrated normal mast cell architecture with no evidence of mast cell degranulation. Opioid effects on wheal and flare responses and mast cell degranulation appear independent of opioid analgesic potency. Opioids produce cutaneous vascular responses dependent on both histamine release from mast cells and direct effects on the vasculature. Wheal and flare responses of opioids appear to represent an indicator of systemic histamine release only if they are of the same magnitude as that produced by an equimolar intradermal histamine injection.

UR - http://www.scopus.com/inward/record.url?scp=0024539489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024539489&partnerID=8YFLogxK

M3 - Article

VL - 70

SP - 756

EP - 760

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 5

ER -